{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:39:03Z","timestamp":1790516343841,"version":"4.1.0"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T00:00:00Z","timestamp":1526860800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","award":["4100111"],"award-info":[{"award-number":["4100111"]}],"id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0195751","type":"journal-article","created":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T14:21:06Z","timestamp":1526912466000},"page":"e0195751","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":31,"title":["A monoclonal antibody targeting amyloid \u03b2 (A\u03b2) restores complement factor I bioactivity: Potential implications in age-related macular degeneration and Alzheimer\u2019s disease"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3855-0246","authenticated-orcid":true,"given":"Kameran","family":"Lashkari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianna","family":"Teague","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Qing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan M.","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,5,21]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.preteyeres.2016.04.003","article-title":"Risk factors and biomarkers of age-related macular degeneration","volume":"54","author":"NG Lambert","year":"2016","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40246-016-0079-x","article-title":"AMD and the alternative complement pathway: genetics and functional implications","volume":"10","author":"PL Tan","year":"2016","journal-title":"Hum Genomics"},{"issue":"23","key":"ref3","doi-asserted-by":"crossref","first-page":"14682","DOI":"10.1073\/pnas.222551899","article-title":"Drusen proteome analysis: An approach to the etiology of age-related macular degeneration","volume":"99","author":"JW Crabb","year":"2002","journal-title":"PNAS"},{"issue":"7","key":"ref4","doi-asserted-by":"crossref","first-page":"a017194","DOI":"10.1101\/cshperspect.a017194","article-title":"The proteomics of drusen","volume":"4","author":"JW Crabb","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.preteyeres.2009.11.003","article-title":"The pivotal role of the complement system in aging and age-related macular degeneration: Hypothesis re-visited","volume":"29","author":"DH Anderson","year":"2010","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1167\/iovs.07-1072","article-title":"Complement-Associated Deposits in the Human Retina","volume":"49","author":"A Seth","year":"2008","journal-title":"Investigative Opthalmology & Visual Science"},{"issue":"12","key":"ref7","doi-asserted-by":"crossref","first-page":"5818","DOI":"10.1167\/iovs.09-3928","article-title":"Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes","volume":"50","author":"R Reynolds","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5720","key":"ref8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1126\/science.1110189","article-title":"Complement factor H polymorphism and age-related macular degeneration","volume":"308","author":"AO Edwards","year":"2005","journal-title":"Science"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ophtha.2011.07.056","article-title":"Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration","volume":"119","author":"D Smailhodzic","year":"2012","journal-title":"Ophthalmology"},{"issue":"11","key":"ref10","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/ng.2741","article-title":"Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degeneration","volume":"45","author":"JM Seddon","year":"2013","journal-title":"Nat Genet"},{"issue":"7","key":"ref11","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/ng.2640","article-title":"A functional variant in the CFI gene confers a high risk of age-related macular degeneration","volume":"45","author":"JP van de Ven","year":"2013","journal-title":"Nat Genet"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.exer.2003.10.011","article-title":"Characterization of \u03b2 amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration","volume":"78","author":"DH Anderson","year":"2004","journal-title":"Experimental Eye Research"},{"issue":"Suppl 1","key":"ref13","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1471-4159.2011.07458.x","article-title":"'Clinical trials in Alzheimer's disease': immunotherapy approaches","volume":"120","author":"J Delrieu","year":"2012","journal-title":"J Neurochem"},{"issue":"Suppl 1","key":"ref14","doi-asserted-by":"crossref","first-page":"S204","DOI":"10.1016\/j.neuroimage.2010.06.020","article-title":"Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model","volume":"54","author":"M Koronyo-Hamaoui","year":"2011","journal-title":"Neuroimage"},{"issue":"10","key":"ref15","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1172\/JCI24635","article-title":"The potential role of amyloid beta in the pathogenesis of age-related macular degeneration","volume":"115","author":"T Yoshida","year":"2005","journal-title":"J Clin Invest"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1167\/iovs.12-10849","article-title":"Inflammatory mediators induced by amyloid-beta in the retina and RPE in vivo: implications for inflammasome activation in age-related macular degeneration","volume":"54","author":"RT Liu","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s12035-014-8886-3","article-title":"Beta-Amyloid Precursor Protein (betaAPP) Processing in Alzheimer's Disease (AD) and Age-Related Macular Degeneration (AMD)","volume":"52","author":"Y Zhao","year":"2015","journal-title":"Mol Neurobiol"},{"key":"ref18","first-page":"1253","article-title":"Complement factor I and age-related macular degeneration","volume":"20","author":"P Alexander","year":"2014","journal-title":"Molecular Vision"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"712","DOI":"10.4049\/jimmunol.181.1.712","article-title":"Altered function of factor I caused by amyloid \u00df: Implications for pathogenesis of age-related macular degeneration from drusen","volume":"181","author":"J Wang","year":"2008","journal-title":"The Journal of Immunoloyg"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/jcp.21742","article-title":"Amyloid-beta up-regulates complement factor B in retinal pigment epithelial cells through cytokines released from recruited macrophages\/microglia: Another mechanism of complement activation in age-related macular degeneration","volume":"220","author":"J Wang","year":"2009","journal-title":"J Cell Physiol"},{"issue":"6","key":"ref21","doi-asserted-by":"crossref","first-page":"e65518","DOI":"10.1371\/journal.pone.0065518","article-title":"Systemic administration of Abeta mAb reduces retinal deposition of Abeta and activated complement C3 in age-related macular degeneration mouse model","volume":"8","author":"I Catchpole","year":"2013","journal-title":"PloS one"},{"issue":"28","key":"ref22","doi-asserted-by":"crossref","first-page":"E279","DOI":"10.1073\/pnas.1100901108","article-title":"Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration","volume":"108","author":"JD Ding","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"e0098153","DOI":"10.1371\/journal.pone.0098153","article-title":"First administration of the Fc-attenuated anti-beta amyloid antibody GSK933776 to patients with mild Alzheimer's disease: a randomized, placebo-controlled study","volume":"10","author":"N Andreasen","year":"2015","journal-title":"PloS one"},{"issue":"11","key":"ref24","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1001\/archopht.123.11.1484","article-title":"The Agre-Related Eye Disease Study severity scale for age-related macular degeneration. AREDS report No. 17","volume":"123","author":"M Davis","year":"2005","journal-title":"Archives of Ophthalmology"},{"issue":"4","key":"ref25","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1080\/10543409808835266","article-title":"A global model to define the bahavior of partial agonists (bell-shaped dose-response inducers) in pharmacological evaluation of activity in the presence of the full agonist","volume":"8","author":"K Ghosh","year":"1998","journal-title":"Journal of Biopharmaceutical Statistics"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.2517-6161.1964.tb00553.x","article-title":"An analysis of transformations","volume":"26","author":"GEP Box","year":"1964","journal-title":"J Roy Statist Soc Series B"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/00401706.1974.10489207","article-title":"Correcting inhomogeneity of variance with power transformation weighting","volume":"16","author":"GH, WJ Box","year":"1974","journal-title":"Technometrics"},{"key":"ref28","article-title":"A language and environment for statistical computing","author":"RC Team","year":"2013","journal-title":"R Foundation for Statistical Computing"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"367","DOI":"10.4049\/jimmunol.173.1.367","article-title":"Human Complement Factor I Does Not Require Cofactors for Cleavage of Synthetic Substrates","volume":"173","author":"SA Tsiftsoglou","year":"2004","journal-title":"The Journal of Immunology"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1167\/iovs.09-4207","article-title":"Soluble and mature amyloid fibrils in drusen deposits","volume":"51","author":"JM Isas","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"ref31","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/eye.2015.100","article-title":"Dementia of the eye: the role of amyloid beta in retinal degeneration","volume":"29","author":"JA Ratnayaka","year":"2015","journal-title":"Eye"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.exer.2005.05.007","article-title":"PIgment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration","volume":"82","author":"IA Bhutto","year":"2006","journal-title":"Exp Eye Res"},{"issue":"44","key":"ref33","doi-asserted-by":"crossref","first-page":"18751","DOI":"10.1073\/pnas.0905010106","article-title":"An essential role for RPE-derived souble VEGF in the maintenance of the choriocapillaris","volume":"106","author":"M Saint-Geniez","year":"2009","journal-title":"PNAS"},{"issue":"12","key":"ref34","first-page":"57","article-title":"Are systemic levels of amyloid \u03b2 altered in patients with geographic atrophy?","volume":"57","author":"K Lashkari","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1167\/iovs.09-3622","article-title":"Microarray analysis identifies changes in inflammatory gene expression in response to amyloid-beta stimulation of cultured human retinal pigment epithelial cells","volume":"51","author":"KH Kurji","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"16","key":"ref36","first-page":"1","article-title":"System-level analysis of age-related macular degeneration reveals global biomarkers and phenotype-specific functional networks","volume":"4","author":"AM Newman","year":"2012","journal-title":"Genome Medicine"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/ejhg.2008.140","article-title":"Variation near complement factor I is associated with risk of advanced AMD","volume":"17","author":"JA Fagerness","year":"2009","journal-title":"Eur J Hum Genet"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0195751","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T18:15:00Z","timestamp":1720289700000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0195751"}},"subtitle":[],"editor":[{"given":"Simon J.","family":"Clark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,5,21]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0195751","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.17504\/protocols.io.nrrdd56","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,21]]}}}